131 related articles for article (PubMed ID: 3129456)
1. Clinical and electrophysiologic effects of flecainide in patients with refractory ventricular tachycardia.
Capparelli EV; Kluger J; Regnier JC; Chow MS
J Clin Pharmacol; 1988 Mar; 28(3):268-75. PubMed ID: 3129456
[TBL] [Abstract][Full Text] [Related]
2. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
[TBL] [Abstract][Full Text] [Related]
3. Clinical and electrophysiologic assessment of oral flecainide acetate for recurrent ventricular tachycardia: evidence for exacerbation of electrical instability.
Oetgen WJ; Tibbits PA; Abt ME; Goldstein RE
Am J Cardiol; 1983 Oct; 52(7):746-50. PubMed ID: 6624666
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
[TBL] [Abstract][Full Text] [Related]
5. Chronic flecainide therapy selected by electrophysiology testing of intravenous flecainide.
Somberg JC; Tepper D; Sacher H; Schwarz J
Am Heart J; 1987 Jul; 114(1 Pt 1):18-25. PubMed ID: 3111236
[TBL] [Abstract][Full Text] [Related]
6. Flecainide and amiodarone: combined therapy for refractory tachyarrhythmias in infancy.
Fenrich AL; Perry JC; Friedman RA
J Am Coll Cardiol; 1995 Apr; 25(5):1195-8. PubMed ID: 7897134
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of combination therapy with amiodarone and type I agents for treatment of inducible ventricular tachycardia.
Jung W; Mletzko R; Manz M; Nitsch J; Lüderitz B
Pacing Clin Electrophysiol; 1993 Apr; 16(4 Pt 1):778-88. PubMed ID: 7683805
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia.
Saksena S; Rothbart ST; Shah Y; Cappello G
Am J Cardiol; 1984 Aug; 54(3):347-52. PubMed ID: 6465016
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of flecainide in pacing-induced sustained ventricular tachyarrhythmias: correlation to clinical parameters and tachycardia-characteristics.
Podczeck A; Borggrefe M; Bartels K; Breithardt G
Eur Heart J; 1989 Oct; 10(10):928-34. PubMed ID: 2513204
[TBL] [Abstract][Full Text] [Related]
10. [Estimation of the long-term efficacy of anti-arrhythmia treatment with flecainide in ventricular tachycardia].
Fauchier JP; Cosnay P; Babuty B; Moquet B; Rouesnel P; Estepo J
Arch Mal Coeur Vaiss; 1990 Jan; 83(1):77-83. PubMed ID: 2106308
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
Purcaro A; Capestro F; Ciampani N; Fratadocchi GB; Mazzanti M; Costantini C; Molini E
G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of postmyocardial infarction patients with ventricular tachycardia or ventricular fibrillation treated with amiodarone.
Strasberg B; Kusniec J; Zlotikamien B; Mager A; Sclarovsky S
Am J Cardiol; 1990 Sep; 66(7):673-8. PubMed ID: 2399883
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
Hellestrand KJ
Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
[TBL] [Abstract][Full Text] [Related]
14. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
Veltri EP; Reid PR; Platia EV; Griffith LS
Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiologic parameters to predict clinical recurrence of ventricular tachycardia in patients under electrophysiologic study-guided effective pharmacological therapy.
Niwano S; Yamaura M; Yoshizawa N; Moriguchi M; Kitano Y; Aizawa Y; Izumi T
Jpn Circ J; 1999 Sep; 63(9):674-80. PubMed ID: 10496481
[TBL] [Abstract][Full Text] [Related]
16. Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy.
Poll DS; Marchlinski FE; Buxton AE; Doherty JU; Waxman HL; Josephson ME
Circulation; 1984 Sep; 70(3):451-6. PubMed ID: 6744550
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of nadolol alone or in combination with a type IA antiarrhythmic drug in sustained ventricular tachycardia: a prospective study.
Munsif AN; Saksena S
Pacing Clin Electrophysiol; 1989 Nov; 12(11):1816-26. PubMed ID: 2478982
[TBL] [Abstract][Full Text] [Related]
19. Rapid suppression of flecainide-induced incessant ventricular tachycardia with high-dose intravenous amiodarone.
Sagie A; Strasberg B; Kusniec J; Sclarovsky S; Rechavia E; Agmon J
Chest; 1988 Apr; 93(4):879-80. PubMed ID: 3127126
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiologic predictors of long-term clinical outcome with amiodarone for refractory ventricular tachycardia secondary to coronary artery disease.
Yazaki Y; Haffajee CI; Gold RL; Bishop RL; Alpert JS
Am J Cardiol; 1987 Aug; 60(4):293-7. PubMed ID: 3618488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
